logo
Sun Pharma launches alopecia drug Leqselvi in US after settling patent dispute

Sun Pharma launches alopecia drug Leqselvi in US after settling patent dispute

Mint5 days ago
Sun Pharma on Monday announced it has settled a patent row with American biopharma company Incyte Corporation over its hair-loss drug, paving the way for its launch in the US. The Mumbai-based drugmaker, embroiled in the lawsuit since last year, launched the specialty drug in the world's largest pharmaceutical market on Monday.
Leqselvi (oral deuruxolitinib) is indicated for treatment of adults with severe alopecia areata.
Under the terms of settlement and licensing agreement, the two companies will seek a dismissal of the pending litigation in the United States District Court for the District of New Jersey, the company said in a release.
Sun and Incyte will mutually release each other of all claims that were raised or could have been raised in that litigation. Incyte has also granted a limited, non-exclusive licence to Sun to US patents no. 9,662,335 and other related patents. This licence covers oral deuruxolitinib for certain agreed-upon non-hematology-oncology indications including alopecia areata, the company said.
In return, Sun will pay Incyte an upfront amount, as well as ongoing royalty payments until expiry of the patents.
The company did not reveal other specific terms of the settlement.
In April 2025, Sun Pharma received a favourable ruling from the US Court of Appeals for the Federal Circuit, which vacated a preliminary injunction on Leqselvi's launch, lifting restrictions on the launch.
Sun received approval from the US Food and Drug Administration for Leqselvi in July 2024. Soon after the regulator's approval, Incyte Corporation filed a patent infringement lawsuit against Sun Pharma, alleging that Leqselvi infringed upon its existing patents, delaying the launch.
In November 2024, the US District Court of New Jersey granted a preliminary injunction, halting Leqselvi's launch in the US until the lawsuit was resolved.
Sun Pharma on Monday announced the launch of Leqselvi in the US, in a separate release. The drug will be available for prescription in 8mg tablets in the country.
'As a company committed to launching new therapeutic options which address the unmet needs of patients, adding LEQSELVI to our dermatology portfolio represents a key milestone for the business and an important advancement for the alopecia areata community," said Richard Ascroft, CEO, Sun Pharma North America, in the release.
Leqselvi demonstrated rapid results in clinical trials with one third of patients regaining almost all of their hair by week 24. Some patients (3%) achieved 80% or more scalp coverage as fast as 8 weeks.
Leqselvi is expected to be a $200 million opportunity for Sun Pharma in 3-4 years after launch, according to brokerage Elara Capital.
Sun Pharma's shares ended 0.58% higher at ₹ 1,681.70 apiece on NSE on Monday.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

India Cements Q1 results: ICL reports net loss at ₹133 crore. Check details
India Cements Q1 results: ICL reports net loss at ₹133 crore. Check details

Mint

timean hour ago

  • Mint

India Cements Q1 results: ICL reports net loss at ₹133 crore. Check details

New Delhi, Jul 19 (PTI) India Cements Ltd (ICL), now part of the Aditya Birla Group, on Saturday reported a consolidated net loss of ₹ 132.90 crore for the first quarter ended June 2025. It had reported a net profit of ₹ 58.47 crore a year ago, according to a BSE filing by ICL, now a subsidiary of UltraTech Cement. Its revenue from operations was marginally down at ₹ 1,024.74 crore in the June quarter of FY26. This was ₹ 1,026.76 crore in the corresponding quarter of the last fiscal. The total expenses of ICL declined 12.43 per cent to ₹ 1,042.19 crore in the first quarter of FY26. ICL's total income, which includes other income, in the June quarter was marginally down at ₹ 1,033.85 crore. UltraTech, the country's leading cement maker, acquired the promoter's stake in the South-based cement maker. Consequently, ICL became a subsidiary of UltraTech Cement, with effect from December 24, 2024. "PAT before onetime exceptional items was a negative ₹ 9.13 crore compared to negative ₹ 182.21 crore over the same period last year," said an earnings statement by the company. It has refinanced its debt, resulting in a significant reduction in finance costs to ₹ 26.58 crore from ₹ 82.36 crore in the corresponding quarter of the previous year. According to ICL, it is "deriving benefits of synergy" with its holding company, UltraTech, which will improve its efficiency. "The company is planning a capital expenditure programme over the next 2 years for improving efficiency and reducing operating costs, increasing the share of renewable power and improving safety standards," said ICL. It further added that its profitability is expected to improve further as the benefit of this capex programme starts flowing together with synergies from economies of scale, wider distribution network and stronger balance sheet.

India Cements Slips Into Rs 133 Crore Loss In Q1, Revenue Flat
India Cements Slips Into Rs 133 Crore Loss In Q1, Revenue Flat

India.com

timean hour ago

  • India.com

India Cements Slips Into Rs 133 Crore Loss In Q1, Revenue Flat

New Delhi: India Cements Limited, a subsidiary of UltraTech cement, on Saturday slipped into losses in the first quarter of the financial year (Q1 FY26), reporting a net consolidated loss of Rs 132.90 crore. The Aditya Birla Group-owned cement company had posted a net consolidated profit of Rs 58.47 crore in the corresponding quarter a year ago (Q1 FY25). In the last quarter (Q1 FY25), the company's profit stood at Rs 14.68 crore, as per its exchange filing. Meanwhile, its revenue from operation remained flat at Rs 1,024.74 crore (year-on-year) from Rs 1,026.76 crore in the same period a year earlier. However, the revenue declined 14 per cent sequentially from Rs 1,197.30 crore in the preceding quarter. The company's expenses for the quarter under review stood at Rs 1,042.19 crore, falling slightly as compared to Rs 1,190.24 crore in Q1 FY25, according to the filing. However, the expenses were higher than the total revenue (revenue from operation + other income) of Rs 1,033.85 crore, dragging cement manufacturing firm in the losses. Profit after tax (PAT) before one-time exceptional items was a negative Rs 9.13 crore compared to negative Rs 182.21 crore over the same period last year, according to the filing. UltraTech acquired the promoter's stake in the south India-based cement maker. It later became a subsidiary of UltraTech Cement, with effect from December 24, 2024. "The Company is planning a capital expenditure programme over the next 2 years for improving efficiency and reducing operating costs; increasing share of renewable power and improving safety standards," it said in the filing. On the future outlook, the cement manufacturer said that India Cements is poised to grow stronger. In last quarter, India Cements reported a 3.11 per cent annual fall in its revenue to Rs 1,197.3 crore.

Who was Edwin J. Feulner? Conservative hero and Heritage Foundation founder dies at 83 after driving Trump's Project 2025 vision
Who was Edwin J. Feulner? Conservative hero and Heritage Foundation founder dies at 83 after driving Trump's Project 2025 vision

Time of India

timean hour ago

  • Time of India

Who was Edwin J. Feulner? Conservative hero and Heritage Foundation founder dies at 83 after driving Trump's Project 2025 vision

Heritage Foundation founder Edwin J. Feulner dies at 83: How the conservative icon shaped U.S. politics and Trump's agenda- Edwin J. Feulner, the co-founder and longest-serving president of the Heritage Foundation, passed away on Friday at the age of 83. A central figure in modern American conservatism, Feulner led the think tank from 1977 to 2013 and returned briefly from 2017 to 2018. Under his leadership, the Heritage Foundation transformed from a small Washington-based group into a major policy force that reshaped Republican thinking—especially during the Reagan era and again under Donald Trump. Feulner's influence extended beyond policy papers. He played a direct role in crafting conservative agendas, most recently through the controversial Project 2025, which outlines a blueprint for a potential second Trump administration. His legacy is deeply tied to the rise of organized conservative policy-making in Washington. Explore courses from Top Institutes in Select a Course Category Data Analytics Cybersecurity Others Leadership Digital Marketing Design Thinking Data Science MCA healthcare Public Policy Finance Degree Project Management PGDM MBA Technology Healthcare Data Science Operations Management CXO Artificial Intelligence Management Product Management others Skills you'll gain: Data Analysis & Visualization Predictive Analytics & Machine Learning Business Intelligence & Data-Driven Decision Making Analytics Strategy & Implementation Duration: 12 Weeks Indian School of Business Applied Business Analytics Starts on Jun 13, 2024 Get Details What made Edwin J. Feulner a key figure in the conservative movement? Feulner helped launch the Heritage Foundation in 1973, a time when conservative policy ideas had little institutional support in D.C. When he took over as president in 1977, he envisioned a new kind of think tank—one that could produce timely, actionable policy proposals, ready for lawmakers. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Unsold Container Homes in Nueva Ecija - Prices You Won't Believe! Shipping Container Homes | Search Ads Search Now Undo His vision paid off. By the time Ronald Reagan entered the White House in 1981, Heritage had already published 'Mandate for Leadership,' a 3,000-page conservative playbook that became required reading for Reagan's transition team. That model—providing ready-to-implement policies—revolutionized think tank influence in American politics. Feulner's mantra, 'people are policy,' summed up his approach: Build networks, place people in government, and influence policy from within. Live Events How did Feulner impact the Reagan and Trump administrations? During the Reagan years, Feulner's Heritage Foundation pushed for free-market policies, deregulation, and a strong national defense. The group's ideas helped shape tax reform, welfare policy, and foreign policy throughout the 1980s. Fast forward to Donald Trump's presidency, and Feulner was again at the center of conservative strategy. He served on Trump's transition team and co-authored the afterword to Project 2025, a document filled with right-wing policy proposals in case Trump returns to office. Project 2025 has sparked heated debate—praised by supporters for its clarity and criticized by opponents for its extreme views. According to Heritage President Kevin Roberts and Board Chair Barb Van Andel-Gaby, Feulner 'helped shape every fiber of the conservative movement—and still does.' What is Project 2025 and why was Feulner involved? Project 2025, led by the Heritage Foundation, is a transition plan designed for a future Trump administration. It includes staffing strategies, policy proposals, and structural changes aimed at strengthening executive authority and reshaping federal institutions. Feulner's involvement highlights his ongoing influence. Even in his 80s, he remained active—working alongside current Heritage leaders, co-writing sections of the project, and meeting with Donald Trump to discuss its content. His dedication to building conservative institutions never wavered, even as political tides shifted. How did Feulner promote unity in a divided movement? Feulner was known for building coalitions across the conservative spectrum. He brought together libertarians, traditionalists, and nationalists at venues like the Philadelphia Society and through initiatives like the Heritage Strategy Forum. One of his favorite sayings was: 'You win through multiplication and addition, not through division and subtraction.' He believed that unity—not uniformity—was the key to building lasting political power. Roberts and Van Andel-Gaby described Feulner as someone who 'championed a bold, big-tent conservatism.' That philosophy helped Heritage weather political changes and internal ideological battles for decades. What is Edwin Feulner's lasting legacy at the Heritage Foundation? Feulner wrote nine books, served as a congressional aide, and mentored a generation of conservative leaders. But his most visible legacy is the Heritage Foundation itself. Under his watch, it became a $100-million-a-year operation with deep ties to Congress, the White House, and grassroots networks. Roberts said Feulner's words still echo in the halls of Heritage: 'In Washington, there are no permanent victories and no permanent defeats.' That mindset continues to guide the think tank's work today. The Foundation has vowed to carry Feulner's mission forward 'with courage, integrity, and determination.' His focus on policy, people, and principle remains at the core of its strategy. Who survives Edwin J. Feulner and what's next for Heritage? Feulner is survived by his wife Lina, their children, and grandchildren. The Heritage Foundation has not released the cause of death. Though Feulner is gone, his ideas, leadership style, and institutional legacy remain central to the conservative movement's future—especially as debates heat up around Project 2025 and the 2024 presidential election. As Heritage leadership put it: 'Thank you for showing us what one faithful, fearless man can do when he refuses to cede ground in the fight for self-governance.' FAQs: What was Edwin J. Feulner's role in the Heritage Foundation? He was the co-founder and longest-serving president, transforming it into a leading conservative think tank. What is Project 2025 and why was Feulner involved? Project 2025 is a conservative policy plan for a possible Trump second term, co-authored by Feulner to guide future governance.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store